October 31, 2018 โ Amgen announced a new Repatha cardiovascular outcomes study (FOURIER) analysis evaluating the effects ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
October 31, 2018
October 31, 2018 โ Recent statin and medication advances have led some researchers to suggest surgical treatments for ...
October 31, 2018
October 17, 2018 โ The U.S. Food and Drug Administration (FDA) has cleared anย additional indication for rivaroxaban ...
October 17, 2018
October 11, 2018 โ Novel results from the landmark EMPA-REG OUTCOME trial suggest that treatment with Jardiance ...
October 11, 2018
October 4, 2018 โ Pulmonary artery denervation (PADN) is associated with significant improvements in hemodynamic and ...
October 04, 2018
Ashish Pershad, M.D., medical director, structural heart program, Banner University Medical Heart Institute, Phoenix ...
October 01, 2018
September 7, 2018 โ The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival ...
September 07, 2018
September 7, 2018 โ A new Phase 2 clinical trial looks to confirm the efficacy and safety of Thrombolytic Science LLCโs ...
September 07, 2018
September 6, 2018 โ Tafamidis is the first treatment to improve survival and reduce hospitalizations in a rare heart ...
September 06, 2018
September 5, 2018 โ Aspirin prevented serious vascular events in patients with diabetes who did not already have ...
September 05, 2018
September 4, 2018 โ The jury is still out on whether people at moderate risk of a first heart attack or stroke should ...
September 04, 2018
August 31, 2018 โ Use of an oral anticoagulant in medically ill patients for 45 days following hospital discharge ...
August 31, 2018
August 27, 2018 โ Blood pressure and cholesterol-lowering drugs continue to improve survival in patients with hypertensi ...
August 27, 2018
June 29, 2018 โ Results from the MERCURY PE study showed that low-risk pulmonary embolism (PE) patients treated with Xar ...
June 29, 2018
June 27, 2018 โ Results from a 902-person, five-country survey of people living with atrial fibrillation (AF) reinforce ...
June 27, 2018ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now